Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E2WF
|
||||
Former ID |
DCL000910
|
||||
Drug Name |
ORG 34517/34850
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Severe mood disorders [ICD9: 296; ICD10:F30-F39] | Phase 2 | [536580] | ||
Company |
Organon
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H14N6
|
||||
Canonical SMILES |
C1CC(=NN=C(N)N)C2=C1C(=CC=C2)C(=N)N
|
||||
InChI |
1S/C11H14N6/c12-10(13)8-3-1-2-7-6(8)4-5-9(7)16-17-11(14)15/h1-3H,4-5H2,(H3,12,13)(H4,14,15,17)/b16-9+
|
||||
InChIKey |
CYPGNVSXMAUSJY-CXUHLZMHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Antagonist | [536580] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.